bio-regulatory-affairs-995x60 bio-regulatory-affairs-995x60

WHITE PAPERS & CASE STUDIES

PRODUCTS & SERVICES

From the production floor to the shipping door, your unique clinical or commercial requirements will be fulfilled at each step of the process.

The Empower RF Model 2240 is engineered for robust pulse and continuous-wave (CW) applications within the C-band frequency range and efficiency in a compact 3RU form factor.

KRYTAR's 4-50 GHz directional couplers are crafted for system applications necessitating external leveling, precise monitoring, signal mixing, or swept transmission and reflection measurements.

Nitrowave RF coaxial cables offer improved stability with flexure over time. The coaxial structure is designed to meet the demands of aerospace, defense, datacom, and many other growing markets.

The PE42447 is an SP4T RF switch that supports a frequency range from 10 MHz to 8 GHz. It delivers extremely low insertion loss and high linearity with high input power handling.

The LVA-6183PN+ is a wideband, ultra-low phase noise MMIC amplifier perfect for use with low noise signal sources and in sensitive transceiver chains. 

As the industry’s most advanced digital construction management system, Trimble e-Builder enables efficiencies across the entire design-build lifecycle, with a smooth transition to the operation phase. Reduce risk, enhance collaboration and improve outcomes using the industry-leading digital project delivery software for owners.

Antibody drug conjugates (ADCs) are the emerging class of anti-cancer therapeutic drugs. ADCs combine an antibody capable of recognizing cancer cells and cytotoxic small-molecule drugs via cleavable or non-cleavable linkers, thereby transforming the 3-unit combination into a targeted therapeutic drug for cancer treatment. In recent years, ADCs have rapidly developed and there are not only more than 14 approved drugs on the market but also many investigational drugs undergoing clinical trials. Furthermore, ADCs have shown potential for treating various diseases beyond cancer, such as Autoimmune disorders, Infectious diseases, Inflammatory conditions and so on.  

WEBINAR